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dulating severity and relapsed after a 
latent period of another 2 weeks. Al-
though the isolate was highly resistant 
to clarithromycin in vitro, the patient 
improved clinically as symptoms dis-
appeared. Results of stool cultures tak-
en 5 weeks after resolution of clinical 
symptoms were negative. The clinical 
course of this patient’s illness suggests 
that S. Agama may cause self-limiting 
infections and asymptomatic shed-
ding, as do other nontyphoidal Salmo-
nella infections. The course of disease 
may be affected by the ingested infec-
tive dose, host factors, and virulence 
of S. Agama isolates.
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Small Anellovirus 
Infections in 
Korean Children
To the Editor: Recently, Jones 
et al. (1) identiﬁ   ed circular DNA 
sequences, classiﬁ  ed  as  Anellovirus 
genus, in plasma from patients with 
acute viral infection syndromes. 
These anelloviruses were then la-
beled as “small anellovirus (SAV)” 
because of their smaller genomes 
when compared with Torque Teno Vi-
rus (TTV) and Torque Teno Mini Vi-
rus (TTMV), which have small, cir-
cular, single-stranded DNA genomes. 
Although anelloviruses are not asso-
ciated with any speciﬁ  c disease, TTV 
has been suggested to play a role in 
acute respiratory disease (ARD) and 
in asthma of children (2,3).
Kawasaki disease and Henoch-
Schonlein purpura are important 
vasculitis disorders in children, pos-
sibly triggered by unknown infec-
tious agents. Recently, Gergely et al. 
(4) reported that molecular mimicry 
involving TTV and the generation of 
autoantibodies may have a role in the 
pathogenesis of systemic lupus ery-
thematosus. The purpose of our study 
was to investigate the prevalence of 
SAV and its association with various 
clinical diseases in children.
The study population comprised 
81 serum samples from healthy chil-
dren and 151 serum samples from 
children hospitalized with hepatitis 
(81 cases), ARD (40 cases), Kawa-
saki disease (12 cases), or Henoch-
Schonlein purpura (18 cases) during 
the period January 2002–June 2006. 
Nasopharyngeal aspirates paired with 
serum samples were collected from 34 
children with ARD, including upper 
respiratory tract infections, pneumo-
nia, and acute bronchiolitis. Samples 
were collected after informed consent 
was obtained at admission from pa-
tients’ parents.
PCRs for SAV were performed to 
amplify a 5′ noncoding region of SAV 
Figure. Photograph taken at a local street market in Gabon shows a lizard in a basket of 
onions, which are frequently eaten uncooked. Salmonella enterica subspecies enterica 
serotype Agama has been isolated from lizards in Africa.
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with speciﬁ  c primers, as described pre-
viously (5). PCR products were directly 
sequenced, and nucleotide sequences 
were registered in GenBank (acces-
sion nos. DQ978791–DQ9788810). 
The χ2 test with Yates correction and 
Mann-Whitney U-test were used for 
statistical comparison by using Med-
Calc (MedCalc Software, Mariakerke, 
Belgium). A p value <0.05 was deﬁ  ned 
as statistically signiﬁ  cant.
In our study population, serum 
SAV DNA was detected in 28 (34.5%) 
of 81 children in the control group and 
in 66 (43.7%) of 151 children in the 
disease group. In the healthy control 
group, the SAV-positive rate was 7.4% 
(6/81) in children <12 months of age, 
16.0% (13/81) in children 1–4 years of 
age, and 11.1% (9/81) in children 5–15 
years of age. In the disease group, the 
SAV-positive rate was 35.8% (29/81) in 
patients with hepatitis, 67.5% (27/40) in 
ARD, 50% (6/12) in Kawasaki disease, 
and 22.2% (4/18) in Henoch-Schonlein 
purpura, respectively (Table). Among 
34 nasopharyngeal aspirates collected 
from children with ARD, SAV DNA 
was detected in 19 (55.9%). Codetec-
tion of SAV and respiratory syncytial 
virus in nasopharyngeal aspirates was 
observed in 4 patients.
Percent similarity of nucleotide 
sequence of PCR products was 99% 
among SAV isolates. To our knowledge, 
this is the ﬁ  rst report of SAV infections 
in children. The prevalence and role of 
SAV in clinical diseases have yet to be 
determined. Recently, Biagini et al. (5) 
reported that the prevalence of SAV 
infection was 20% (12/60) in French 
blood donors. In an Italian study (6), 
the positive rate of SAV DNA was 
9.1% (5/55) in patients with hepatitis C 
compared with 8.6% (3/35) in healthy 
controls. Thus, the prevalence of SAV 
in Korean children is much higher than 
that reported in adults from other coun-
tries (5,6). Further studies are needed to 
conﬁ  rm this ﬁ  nding.
In our study, the prevalence of 
SAV did not differ signiﬁ  cantly  be-
tween the hepatitis group and the 
healthy control group. Our results in-
dicate that SAV presence does not ap-
pear to have a deﬁ  ning role in hepati-
tis, as do TTV or TTMV infection (7). 
In a previous study, several groups of 
viruses, including TTV, were ruled 
out as etiologic agents of Kawasaki 
disease (8), ﬁ  ndings similar to those 
of our study. We found that the preva-
lence of SAV was signiﬁ  cantly higher 
in patients with ARD and that SAV-
positive results from serum were con-
sistent with those of nasopharyngeal 
aspirates in 76% (26/34). These ﬁ  nd-
ings suggest that the respiratory tract 
may be a transmission route of SAV 
in children.
In conclusion, we conﬁ  rmed the 
presence of SAV in serum samples and 
nasopharyngeal aspirates from Korean 
children. A signiﬁ  cantly higher detec-
tion of SAV DNA was observed in 
children with ARD compared with 
healthy children or children with other 
clinical diseases. 
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Antibodies against 
Leptospira spp. in 
Captive Collared 
Peccaries, Peru
To the Editor: Leptospirosis is 
endemic to tropical South America 
and is a major public health problem 
for persons living in some regions 
of the Amazon Basin (1–3). For lo-
cal inhabitants, the collared peccary 
(Tayassu tajacu) represents  a major 
source of meat and income and is 
one of the most hunted species. As a 
result, several farms are attempting 
to produce captive collared peccaries 
(4). Although spirochetes have been 
isolated from bats, marsupials, and 
rodents in the Peruvian Amazon (5), 
local popular game animals have not 
been tested.
From May through December 
2003,  96 collared peccaries from 4 
experimental farms in 2 Amazonian 
provinces of Peru (Loreto and Ucay-
ali) were surveyed for antibodies 
against Leptospira spp. Although the 
initial stock of each farm came from 
the wild, most animals had been born 
in captivity, remained on their respec-
tive farms, and had no contact with an-
imals from the different farms. Blood 
samples were taken from animals that 
were born or maintained on the farm 
for ≥6 months, were in good physi-
cal condition, and showed no signs of 
disease. Samples that had been hemo-
lyzed or otherwise contaminated were 
discarded, leaving optimal samples 
from 96 animals (sex ratio 1:1, 71% 
>1 year of age).
The microscopic agglutination 
test was performed with a panel of 24 
antigens belonging to 17 serogroups 
of Leptospira spp. used for screening 
surveys at the National Leptospirosis 
Reference Laboratory. An additional 
distinct strain, obtained from a febrile 
human patient in the Peruvian Ama-
zon and provisionally designated as 
Var10, was added (2). Serum samples 
were considered positive if they had 
50% agglutination and titers >100 (6). 
Chi-square tests were used for statisti-
cal comparisons of sex and age; sig-
niﬁ  cance was set at p<0.05. 
Among the screened samples, 
64.6% reacted to 15 serovars (strains) 
that belong to 11 serogroups (Table). 
Seroprevalence did not differ signiﬁ  -
cantly in relation to sex or age. Var10 
was the most prevalent (56.2%) strain. 
This strain was isolated from a hu-
man patient in Iquitos (Loreto, Peru) 
and involved in recent outbreaks in 
the northern Peruvian Amazon (2); its 
taxonomic classiﬁ  cation is pending. In 
terms of its distribution, 32 peccaries 
had positive results for Var10 only; 
12 serum samples were reactive to 
>1 known serogroup. Leptospira sp. 
Var10 reacted mainly with serogroups 
Australis and Hebdomadis. Maxi-
mum titers were 6,400 for serogroup 
Tarassovi and 3,200 for Icterohaemor-
raghiae. High seroprevalence (15.6%) 
against serogroup Australis (serovar 
bratislava) has been reported in col-
lared peccaries and in feral and do-
mestic pigs (7,8)
Seroprevalence on the farm in Lo-
reto (n = 27) was 100%. At this farm, 
peccaries are kept near aquatic spe-
cies and numerous ponds of stagnant 
water, which provide an ideal envi-
ronment for the development of Lep-
tospira spp. Because of recent human 
leptospirosis outbreaks in the area (2), 
3 of the peccary caretakers were tested 
for antibodies against Leptospira spp.; 
their results were negative.
Although similar to animals de-
scribed in previous reports (7,9), 
none of the sampled animals showed 
evidence of disease at the time of sam-
pling; however, absence of clinical 
disease does not exclude the possibil-
ity of subclinical or past infections. 
Furthermore, the high prevalence of 
antibodies to multiple serotypes sug-
gests a wide exposure to Leptospira 
spp. Despite reports that suggest the 
collared peccary could act as a res-
ervoir for Leptospira spp. (7,9), the 
ﬁ  nding of high antibody titers in some 
individual animals could indicate that 
collared peccaries are incidental rath-
er than reservoir hosts. However, the 
prevalences found at 4 distant farms 
also indicate that this species could 
play some role in the maintenance and 
spread of leptospirosis in the Amazon 
Basin.
Multiple titers to different se-
rovars or serogroups in the same se-
rum sample are common with sero-
logic testing and difﬁ  cult to interpret. 
Multiple titers can result from cross-
reactions between different serovars 
or from true multiple infections (10). 
Regardless, serologic tests are only 
indicative of exposure to leptospires. 
Further efforts are necessary to isolate 
lepstospires from the urine or renal 
tissue of collared peccaries to con-
ﬁ  rm the presence of spirochetes and 
their  potential  dissemination  into  the        
environment.
Our ﬁ  ndings indicate that persons 
who have contact with collared pec-
caries and their products, particularly 
animal caretakers, researchers, hunt-
ers, and game traders, are at risk for 